企業プロフィール
IceCure Medical 株価・ニュース・カタリスト
- ティッカー:
- ICCM
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Israel
株価パフォーマンス
2.82 USD (-6.62%)
終値
最終更新: 2026年8月17日
11.3M USD
時価総額
株価変動の要因
As of Aug 17, 2026, ICCM closed down 6.62% at $2.82. No new same-company headline was identified in the current news window.
企業概要
Cryoablation Medical Technology
IceCure Medical develops minimally invasive systems that destroy tumors by freezing them as an alternative to surgical removal.
ProSense
The ProSense system uses liquid nitrogen-based probes to create a controlled ice ball around a tumor under image guidance.
Breast Cancer Commercialization
FDA clearance supports use in selected early-stage breast cancer patients, providing the foundation for expanded U.S. installations and disposable probe utilization.
Broader Tumor Applications
The platform is also used or studied in kidney, liver, lung, and other tumors accessible to percutaneous cryoablation.
今後のカタリスト
- The cleaner way to frame IceCure Medical right now is around its latest development priorities. The most useful line from the latest update is and North America May 12, 2026 8:30 am EDT Download as PDF Pent-up demand immediately following FDA clearance generates 46% increase in active customer accounts using ProSense® as.... That should keep the program at the center of the company narrative for now.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。